Europe Biologics Market – Size, Outlook, Trends and Forecast (2024

Europe Biologics Market - Size

Study Period

2018 - 2032

Base Year For Estimation

2025

Forecast Data Period

2026-2032

Historical Data Period

2018-2024

CAGR

7 %

Source: Envision Intelligence Analysis & Experts Insights.

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

The diseases that are treated by biologics are cancer, rheumatoid arthritis and many other rare diseases for which there were no previous treatment options. Biologics come from the new class of protein-based therapeutics that are produced using living organisms, including plants, animals, and microorganisms such as yeast & bacteria. Any medical product that is originated from living organisms is considered to be biologic products.

Europe Biologics Market Size & Growth:

The Europe biologics market was valued to be nearly $XX billion in 2017 and is expected to reach over $XX billion by the end of 2025 with a CAGR of almost XX% during the Europe biologics market forecasts period from 2019-2025. Some of the key drivers that are driving Europe biologics market growth are increasing capital investment from critical players, rising prevalence of chronic diseases, growing demand & higher acceptability for innovative therapies and others. The rise in the prevalence of chronic diseases is driving the Europe market. Increase in population & changes in social behaviour is contributing to a steady rise in these common & costly long-term health problems. The middle class is increasing and the urbanisation fast-tracking, adopting a more inactive lifestyle. This is increasing obesity rates and causing many diseases such as diabetes on top. Based on the World Health Organization report, chronic disease prevalence is expected to rise by 57% by the year 2020. Emerging markets will be hardest hit, as population growth is expected to be most significant in developing nations. Rising prevalence of chronic diseases boosting biologics market. Biologics drugs are highly complex & required to control & maintain throughout the development & production

Europe Biologics Market - Growth

Source: Envision Intelligence Analysis & Experts Insights.

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

process. This regulated environment & quality control procedures involve huge capital investment in the initial state of the process. Additionally, biologics are most susceptible to light, heat conditions, and need an auspicious environment that is not available uniformly across the globe. In most emerging markets, currently, biologics have little presence. Stringent regulatory policies and high-capital investment coupled with limited patient access to reasonable biologics mainly in the developing countries owing to the increasing control and cost for accessing biologics are likely to obstruct the growth of the Europe biologics market. Based on Europe biologics market outlook, cancer application market size is estimated to proliferate. Since the demand for usage of biologics in cancer treatment. According to Europe biologics market analysis, Europe biologics market size will increase eventually high in forecast period from 2019-2025.

Europe Biologics Market Share:

Europe biologics market is classified by type, products, application and geography. By the product, the market in monoclonal antibodies segment of the biologics market is estimated to grow

You can also purchase parts of this report. Do you want to check out a section wise price list

Europe Biologics Market - Porter's Five Force Analysis

Source: Envision Intelligence Analysis & Experts Insights.

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

at the fastest CAGR during the forecast period. Since these antibodies are made by different immune cells that are all clones of a unique parent cell. These antibodies have a monovalent affinity, and they bind to the same epitope to treat cancer. Regarding application, the market in cancer application of the biologics market is

Credibility and
Transparency

We actively recruit consumers, business professionals, and elusive individuals for our research panels, fostering enduring relationships. Our commitment to transparency is evident in the comprehensive listing of primary and secondary data sources, ensuring unwavering credibility in our reports.

Exhaustive
Coverage

Uncover the full spectrum with Envision Intelligence. Our detailed and extensive geographical coverage, coupled with survey consultation services, spans brand tracking, concept testing, and consumer behaviour analysis. Adapt to your evolving needs with scalable market research services that leave no facet unexplored.

Competitive
Edge

Stay ahead with Envision Intelligence. Our reports provide the latest market updates up to the date of purchase. Recognising the urgency of impactful decisions, we deliver timely analyses on the unprecedented choices made by CXOs during the COVID-19 crisis—providing valuable insights at no extra cost.

Golden
pportunities

Unearth hidden gems with Envision Intelligence. Our analysts and consultants conduct a comprehensive strategic sieve analysis, augmented by AI tools, to identify non-obvious, golden, and emerging opportunities. Evaluate possibilities that set you apart in the market.

Top-notch Reportsd
Guaranteed

Experience unparalleled depth with Envision Intelligence. Over 70% of our research is exclusive, establishing us as the premier source for in-depth and extensive market insights. Elevate your decision-making with reports that go beyond the ordinary.

Post Purchase
Support

Empower your journey with Envision Intelligence. Our commitment extends beyond the purchase. Enjoy post-purchase support for three months, with queries addressed within 24 business hours via telephone or email. We stand by you in your quest for ongoing success.